Laurus Labs — Bullish Continuation with Strong Momentum 💊

Labs extended its uptrend with a +2.8% gain to ₹1,031, confirming a bullish continuation after consolidating near ₹1,000. The stock remains one of the strongest performers in the pharma pack, supported by both price action and volume expansion. Technical View: Price broke above ₹1,020 resistance on renewed buying interest, staying firmly above the short-term EMA. RSI (14) near 70, signaling strong momentum; trend still intact without overextension. Volume uptick suggests fresh accumulation — ideal follow-through after prior breakout. Next resistance: ₹1,065–₹1,085 | Support: ₹995 | Bias: Bullish continuation. Fundamental View: Laurus continues to benefit from strong traction in CDMO and non-ARV portfolio. Sequential margin improvement and new product approvals remain key triggers. Analysts remain positive, maintaining “Buy” ratings with targets around ₹1,100–₹1,150. Outlook: Momentum remains intact. Dips toward ₹1,000 may attract buying interest as long as the trend structure holds.